Fraimen et al, testified at FDA meetings, SAEs did not look good coming out of clinical trials and portended safety concerns that fully developed in the post-release EUA era. Now complete safety debacle with World Council for Health, 6/11, calling for complete market withdrawal.
Serious-adverse-events-of-special-interestSource: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4125239
Yahi et al, INSERM, Journal of Infection, explains why mandated products made the infection worse starting with the Delta outbreak. Antibodies generated actually enhanced the illness instead of making it milder. Mechanistic support for concept of antibody-dependent enhancement
Infection-enhancing-anti-SARS-CoV-2-antibodiesView PDF Directly: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351274/pdf/main.pdf
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351274/
Rosenblum et al, Lancet Inf Diseases, 1st few months of the mass indiscriminate program the leading causes of death where autopsy information uploaded was triggered cardiovascular events and breakthrough infections. So product failure early on was second leading cause of death.
Safety-of-mRNA-vaccines-administered-during-the-initial-6-monthsView PDF Directly: https://www.thelancet.com/action/showPdf?pii=S1473-3099%2822%2900054-8
Source: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00054-8/fulltext
Aikawa et al, 16 yr old boy clinical features of myopericarditis. Biopsy of the interventricular septum shows inflammation and increased vascular permeability. Mechanistic drivers for sudden arrhythmic death or myocardial rupture. All sudden deaths should undergo autopsy.
Pericarditis-with-Increased-Vascular-PermeabilityView PDF Directly: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177361/pdf/1349-7235-61-1623.pdf
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177361/
Hause, et al MMWR Dec 31, 2021 demonstrated unacceptable safety data in children including elevations in troponin. Implies subclinical myocardial injury is happening and mothers would have no way of understanding if damage is occurring in their innocent child. Can avoid it all.
Vaccine-Safety-in-Children-Aged-5–11View PDF Directly: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736274/pdf/mm705152a1.pdf
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736274/
Buchan et al, 297 avoidable cases heart damage in Ontario. Kids landing in emergency departments or hospitalized unnecessarily. Should be enjoying school, sports, social life- instead injured and damaged with investigational mandated products. For kids healthy hearts-defer.
Epidemiology-of-Myocarditis-and-Pericarditis-Following-mRNA-VaccinationSource: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2793551
Patalon, preprint, Israel. Natural protection in children excellent. Means vaccine not clinically indicated or medically necessary. CDC says 75% already through it by Feb 2022. Let’s kids be healthy and far away from the genetic code that was never meant for human bodies.
Naturally-acquired-Immunity-against-SARS-CoV-2-in-ChildrenView PDF Directly: https://www.medrxiv.org/content/10.1101/2022.06.20.22276650v1.full.pdf
Source: https://www.medrxiv.org/content/10.1101/2022.06.20.22276650v1.full
Nunez-Castilla, Florida International University, explains why Spike protein causes broad array of different diseases. Large quantity circulatory and tissue Spike is produced every 6 months with forced genetic material after installation in somatic and gamete (sperm/egg) cells.
Potential-Autoimmunity-Resulting-from-Molecular-MimicryView PDF Directly: https://www.mdpi.com/1999-4915/14/7/1415/pdf?version=1656426272
Schonborn et al, NEJM, survivors of VITT (Vaccine Induced Thrombocytic Thrombocytopenia) burned with getting the infection anyway! Fortunately there is no evidence of PF4 interaction with the natural viral illness. Implies the genetic products are the cause of this potentially fatal blood disorder. Avoid more of same!
SARS-CoV-2-Infection-with-a-History-of-VITTView PDF Directly: https://www.nejm.org/doi/pdf/10.1056/NEJMc2206601?articleTools=true
Bottom line and this study out today is telling us what we already knew from prior studies across the last over one year. The study shows that vaccination/injection/inoculation using both mRNA vaccines (Pfizer and Moderna) was related to an increased risk of myocarditis and pericarditis within the first 7 days post vaccination. The study showed that the relationships/associations were especially marked after the second dose, and were existent for both males and females. The study also revealed a trend of enhanced risks towards younger age groups. Moreover, a significant risk was also emerged among males greater than 30 years of age to develop myocarditis and among females over 30 years of age to develop a pericarditis post vaccination.
Specifically, this study (Figures 1 and 2) showed us that for the two vaccines, ‘the risk of myocarditis was increased in the seven days post vaccination. For the BNT162b2 vaccine (Pfizer), odds ratios were 1.8 (95% confidence interval [CI]: 1.3–2.5) for the first dose and 8.1 (95% CI, 6.7–9.9) for the second. The association was stronger for the mRNA-1273 vaccine (Moderna) with odds-ratios of 3.0 (95% CI, 1.4–6.2) for the first dose and 30 (95% CI, 21–43) for the second. The risk of pericarditis was increased in the seven days following the second dose of both vaccines, with odds ratios of 2.9 (95% CI, 2.3–3.8) for the BNT162b2 vaccine and 5.5 (95% CI, 3.3–9.0) for the mRNA-1273 vaccine. Vaccination in the previous 8 to 21 days, with either the BNT162b2 or mRNA-1273 vaccine was not associated with a risk of myocarditis or pericarditis.’
Le Vu et al, Nature Communications, risk includes 10x within just 7 days of taking the vaccine. The absolute risks are considerably greater when the occurrence window is opened. The risks shown are real and are just the tip of the iceberg. Concerning literature.
Age-and-sex-specific-risks-of-myocarditis-and-pericarditisView PDF Directly: https://www.nature.com/articles/s41467-022-31401-5.pdf
Source: https://www.nature.com/articles/s41467-022-31401-5?utm_source=substack&utm_medium=email
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsNous pouvons demander que les cookies soient mis en place sur votre appareil. Nous utilisons des cookies pour nous faire savoir quand vous visitez nos sites Web, comment vous interagissez avec nous, pour enrichir votre expérience utilisateur, et pour personnaliser votre relation avec notre site Web.
Cliquez sur les différentes rubriques de la catégorie pour en savoir plus. Vous pouvez également modifier certaines de vos préférences. Notez que le blocage de certains types de cookies peut avoir une incidence sur votre expérience sur nos sites Web et les services que nous sommes en mesure d’offrir.
Ces cookies sont strictement nécessaires pour vous délivrer les services disponibles sur notre site et pour utiliser certaines de ses fonctionnalités.
Du fait que ces cookies sont absolument nécessaires au bon rendu du site, les refuser aura un impact sur la façon dont il fonctionne. Vous pouvez toujours bloquer ou effacer les cookies via les options de votre navigateur et forcer leur blocage sur ce site. Mais le message vous demandant de les accepter/refuser reviendra à chaque nouvelle visite sur notre site.
Nous respectons votre choix de refuser les cookies mais pour éviter de vous le demander à chaque page laissez nous en utiliser un pour mémoriser ce choix. Vous êtes libre de revenir sur ce choix quand vous voulez et le modifier pour améliorer votre expérience de navigation. Si vous refusez les cookies nous retirerons tous ceux issus de ce domaine.
Nous vous fournissons une liste de cookies déposés sur votre ordinateur via notre domaine, vous pouvez ainsi voir ce qui y est stocké. Pour des raisons de sécurité nous ne pouvons montrer ou afficher les cookies externes d’autres domaines. Ceux-ci sont accessibles via les options de votre navigateur.
Nous utilisons également différents services externes comme Google Webfonts, Google Maps, autres hébergeurs de vidéo. Depuis que ces FAI sont susceptibles de collecter des données personnelles comme votre adresse IP nous vous permettons de les bloquer ici. merci de prendre conscience que cela peut hautement réduire certaines fonctionnalités de notre site. Les changement seront appliqués après rechargement de la page.
Réglages des polices Google :
Réglages Google Map :
Réglages reCAPTCHA :
Intégrations de vidéo Vimeo et Youtube :
